Inflammatory cytokine levels and changes during omalizumab treatment in chronic spontaneous urticaria

Sadeleştirilmiş öğe sayfası
dc.contributor.authorHosgoren\\-Tekin, Selcen
dc.contributor.authorEyuboglu, Irem Peker
dc.contributor.authorAkkiprik, Mustafa
dc.contributor.authorGimenez\\-Arnau, Ana Maria
dc.contributor.authorSalman, Andac
dc.date.accessioned2025-10-16T15:13:20Z
dc.date.issued2024
dc.identifier.doi10.1007/s00403-024-02966-6
dc.identifier.otherWOS:001233071900015
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/5777
dc.publisherSPRINGER
dc.sourceARCHIVES OF DERMATOLOGICAL RESEARCH
dc.subjectOmalizumab
dc.subjectTreatment
dc.subjectCytokine
dc.subjectIL\\-4
dc.subjectIL\\-5
dc.subjectIL\\-10
dc.subjectIL\\-17
dc.subjectIL\\-33
dc.titleInflammatory cytokine levels and changes during omalizumab treatment in chronic spontaneous urticaria
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS